🔬 Johns Hopkins Breakthrough on Hydrogen Sulfide and Brain Health

Recent research from Johns Hopkins University School of Medicine has spotlighted a surprising player in brain function: hydrogen sulfide (H2S), a gas long associated with the smell of rotten eggs, but now recognized as a vital gasotransmitter in the brain. At minuscule concentrations, H2S supports neuron health, memory formation, and protection against neurodegeneration. The study's focus on the protein cystathionine γ-lyase (CSE)—the primary enzyme producing this gas in neurons—reveals its indispensable role in cognitive processes, offering fresh hope in the battle against Alzheimer's disease.

Alzheimer's disease, the most common form of dementia, impacts over 6 million Americans, with numbers projected to rise as populations age. Current treatments offer symptomatic relief but fail to halt progression. This new work positions CSE as a potential therapeutic target, capable of mimicking and exacerbating Alzheimer's hallmarks when absent.

What is Cystathionine γ-Lyase (CSE) and Its Link to H2S?

Cystathionine γ-lyase, commonly abbreviated as CSE, is an enzyme belonging to the transsulfuration pathway. It catalyzes the conversion of cystathionine—a derivative of the amino acid cysteine—into cysteine, ammonia, and crucially, hydrogen sulfide gas. In peripheral tissues, CSE regulates vascular tone and blood pressure, but in the brain, its neuronal expression makes it a key producer of H2S.

Hydrogen sulfide functions as one of three major gasotransmitters in the body, alongside nitric oxide (NO) and carbon monoxide (CO). Unlike traditional neurotransmitters, these gases diffuse freely across cell membranes, modulating signaling without dedicated receptors. In neurons, low levels of H2S promote long-term potentiation (LTP)—a cellular mechanism underlying learning and memory—by enhancing synaptic plasticity and neurotrophin signaling, such as brain-derived neurotrophic factor (BDNF).

The Experimental Design: Probing CSE's Role in Mouse Models

Researchers led by Bindu Paul, Ph.D., and Solomon Snyder, M.D., utilized genetically engineered mice lacking the CSE gene, first developed in 2008 for vascular studies. These CSE knockout (KO) mice were compared to wild-type controls across behavioral, biochemical, and structural analyses.

The cornerstone behavioral assay was the Barnes maze, a dry-land navigation task simulating spatial learning. Mice learn to locate an escape box under aversive bright light and noise. Testing occurred at 2 and 6 months of age to capture age-related progression. Additional probes included immunohistochemistry for neurogenesis markers like doublecortin (DCX), electron microscopy for blood-brain barrier (BBB) integrity, and assays for oxidative stress and DNA damage markers such as 8-oxo-dG.

Collaborators from Case Western Reserve University, Leibniz Institute, and others contributed advanced imaging and proteomics, ensuring robust, multi-institutional validation.

Key Findings: Memory Deficits and Alzheimer's-Like Pathology

At 2 months, CSE KO and wild-type mice performed equivalently, finding the escape within 3 minutes. By 6 months, however, CSE KO mice exhibited profound impairments, failing to locate the shelter—a clear sign of spatial memory loss mirroring early Alzheimer's.

• Reduced hippocampal neurogenesis: DCX-stained newborn neurons were scarce, with impaired migration to memory-critical dentate gyrus regions.
• BBB compromise: Electron micrographs revealed endothelial breaks and pericyte detachment, allowing toxic influx.
• Oxidative damage: Elevated reactive oxygen species (ROS) and DNA lesions, hallmarks of neurodegeneration.

These effects occurred without amyloid-beta plaques or tau tangles, isolating CSE/H2S loss as sufficient to drive pathology.

Photo by Google DeepMind on Unsplash

Mechanisms: How CSE/H2S Supports Neurogenesis and Synaptic Health

CSE-derived H2S sulfhydrates proteins—adding sulfur atoms to cysteines—activating pathways like BDNF/TrkB for neuron survival and dendrite growth. It also mitigates excitotoxicity by modulating NMDA receptors and preserves mitochondrial function against ROS.

In the hippocampus, H2S facilitates adult neurogenesis step-by-step: proliferation of neural progenitors, differentiation into neuroblasts, migration along radial glia, and integration into circuits. CSE KO disrupts this cascade, stalling at early stages.

Prior Johns Hopkins work (2021 PNAS) showed H2S donors like NaGYY reversing Alzheimer's-model deficits by 50% in cognition and activity, underscoring translation potential.Read the 2021 PNAS study.

Parallels to Human Alzheimer's Disease

Human AD brains show depleted H2S and CSE activity, correlating with cognitive decline. The CSE KO phenotype recapitulates prodromal AD: insidious memory loss, hippocampal atrophy, vascular leakage preceding plaques. With 10 million new global cases yearly, targeting CSE could intervene early.

Stakeholders, including the Alzheimer's Association, highlight the need for disease-modifying therapies. This research shifts focus from amyloid to gasotransmitter homeostasis.

Historical Context: Evolution of H2S Research at Universities

H2S's neuroprotective role emerged in the 2000s. Key milestones:

• 2002: Low H2S in AD brains reported (Chinese Academy).
• 2014: Snyder lab links CSE to Huntington's neuroprotection (Johns Hopkins).
• 2021: H2S sulfhydrates GSK3β, inhibiting tau in AD models (PNAS).
• 2025: CSE KO isolates cognitive role (current PNAS).

Johns Hopkins' Solomon Snyder, a neuroscience pioneer, bridges these advances, mentoring talents like Bindu Paul. Case Western's electron microscopy expertise complemented, exemplifying collaborative higher ed research.

Therapeutic Horizons: Boosting CSE Without Toxicity Risks

Direct H2S is toxic above nanomolar levels, but CSE upregulation via gene therapy, small molecules, or sulfhydration mimetics circumvents this. Preclinical donors restored function; clinical trials could adapt these.

Challenges include brain delivery and off-target effects, but NIH-funded extensions promise progress. Impacts: delaying institutionalization, reducing $360B annual US costs.Johns Hopkins press release.

Photo by National Cancer Institute on Unsplash

Expert Perspectives and University Contributions

"CSE alone is a major player in cognitive function," notes Snyder. Paul adds, "Mice lacking CSE were compromised at multiple levels, correlating with Alzheimer’s symptoms."

Suwarna Chakraborty highlights progressive memory decline; Sunil Tripathi emphasizes multi-level deficits. This PNAS paper underscores universities' role in translational neuroscience.Access the full PNAS paper.

Future Directions in Academic Research

Upcoming: human CSE imaging via PET, longitudinal cohorts linking polymorphisms to risk. Cross-disciplinary efforts with pharmacology and AI-drug design at universities like Johns Hopkins could accelerate candidates. For researchers, this opens grants in gasotransmitter biology, neurogenesis.

Optimism tempers caution: rodent-to-human translation varies, but isolated CSE effects bolster validity. Global collaborations, including EU and Asian centers, expand scope.